 However, at the same time, new hepatitis C drugs were released and Rosling went to Japan to buy the drugs needed to treat the infection.He expressed concerns in the media over the restricted use of the new drugs due to high costs, stating that it is a crime not to give every person with hepatitis C access to the drugs.A year after being diagnosed with pancreatic cancer, Rosling died in Sweden on 7 February 2017 at the age of 68.